Your browser doesn't support javascript.
loading
Critical issues in delivery of RNAi therapeutics in vivo.
Rivera, Stephanie; Yuan, Fan.
Afiliação
  • Rivera S; Department of Biomedical Engineering, Duke University, 136 Hudson Hall Durham, NC 27708, USA. stephanie.e.rivera@gmail.com
Curr Pharm Biotechnol ; 13(7): 1279-91, 2012 Jun.
Article em En | MEDLINE | ID: mdl-22201583
ABSTRACT
RNA interference (RNAi) is a fundamental mechanism of gene regulation and has been harnessed to produce a new class of drugs for treatment of various diseases. A key issue in these applications is how to effectively deliver RNAi therapeutics into target cells. This review is focused on advances in RNA delivery in vivo. To achieve it, novel strategies have been developed to enhance stability of RNA in cells and tissues, overcome barriers to transport of RNA or its carriers in the body, and reduce immunogenicity and cytotoxicity of treatment. Approaches to RNA delivery are divided into three categories in this review biological, chemical, and physical. Advantages and disadvantages of each method are discussed. At present, effective delivery of RNAi therapeutics in vivo is still a challenge although significant advances have been made in this field.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Terapia Genética / Sistemas de Liberação de Medicamentos / RNA Interferente Pequeno / Interferência de RNA Idioma: En Ano de publicação: 2012 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Terapia Genética / Sistemas de Liberação de Medicamentos / RNA Interferente Pequeno / Interferência de RNA Idioma: En Ano de publicação: 2012 Tipo de documento: Article